123 related articles for article (PubMed ID: 1594171)
1. A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: quantitative measurement of radioactivity in global skeletal regions of interest.
D'Addabbo A; Rubini G; Mele M; Lauriero F
Nucl Med Commun; 1992 Jan; 13(1):55-60. PubMed ID: 1594171
[TBL] [Abstract][Full Text] [Related]
2. 99Tcm-MDP global skeletal uptake and markers of bone metabolism in patients with bone diseases.
Rubini G; Lauriero F; Rubini D; D'Addabbo A
Nucl Med Commun; 1993 Jul; 14(7):567-72. PubMed ID: 8355916
[TBL] [Abstract][Full Text] [Related]
3. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
Scillitani A; Dicembrino F; Chiodini I; Minisola S; Fusilli S; Di Giorgio A; Garrubba M; D'Aloiso L; Frusciante V; Torlontano M; Modoni S; Trischitta V; Trischitta V; Carnevale V
Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
[TBL] [Abstract][Full Text] [Related]
4. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
[TBL] [Abstract][Full Text] [Related]
5. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
Blake GM; Moore AE; Fogelman I
Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
[TBL] [Abstract][Full Text] [Related]
6. Quantification of diphosphonate uptake based on conventional bone scanning.
Brenner W; Bohuslavizki KH; Sieweke N; Tinnemeyer S; Clausen M; Henze E
Eur J Nucl Med; 1997 Oct; 24(10):1284-90. PubMed ID: 9323270
[TBL] [Abstract][Full Text] [Related]
7. Determination of bone turnover by urinary excretion of 99mTc-MDP.
Thomsen K; Nilas L; Mogensen T; Christiansen C
Eur J Nucl Med; 1986; 12(7):342-5. PubMed ID: 3792363
[TBL] [Abstract][Full Text] [Related]
8. Different patterns of global and regional skeletal uptake of 99mTc-methylene diphosphonate with age: relevance to the pathogenesis of bone loss.
Carnevale V; Dicembrino F; Frusciante V; Chiodini I; Minisola S; Scillitani A
J Nucl Med; 2000 Sep; 41(9):1478-83. PubMed ID: 10994725
[TBL] [Abstract][Full Text] [Related]
9. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
Ergün EL; Kiratli PO; Günay EC; Erbaş B
Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
[TBL] [Abstract][Full Text] [Related]
10. 99Tcm-citrate: a new bone imaging radiopharmaceutical.
Bhatnagar A; Mishra P; Sharma R; Chuttani K; Chakravarty K; Jain CM; Mondal A; Chopra MK; Gupta A
Nucl Med Commun; 1999 Nov; 20(11):1067-76. PubMed ID: 10572918
[TBL] [Abstract][Full Text] [Related]
11. Increased bone metabolism in rheumatoid arthritis as measured by the whole-body retention of 99Tcm methylene diphosphonate.
Rajapakse C; Thompson R; Grennan DM; Winston BM; Patel P; Nuttall PM; Murphy J; Weiss JB
Ann Rheum Dis; 1983 Apr; 42(2):138-41. PubMed ID: 6221703
[TBL] [Abstract][Full Text] [Related]
12. [99m-Tc alendronate as a new option in bone gammagraphy].
Montoya-Molina CE; Sepúlveda-Méndez J; Arteaga-de-Murphy C; Meléndez-Alafort L; Rojas-Bautista JC; López-Alvarenga JC
Rev Invest Clin; 1997; 49(5):373-7. PubMed ID: 9527697
[TBL] [Abstract][Full Text] [Related]
13. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with two simple methods of measurement of 99mTc-methylene diphosphonate body retention in bone disease.
Reschini E; Ulivieri FM; Ortolani S
J Nucl Biol Med (1991); 1991; 35(3):123-30. PubMed ID: 1816867
[TBL] [Abstract][Full Text] [Related]
15. Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
Brenner W; Kampen WU; Brümmer C; von Forstner C; Zuhayra M; Czech N; Muhle C; Henze E
J Nucl Med; 2003 Feb; 44(2):247-51. PubMed ID: 12571217
[TBL] [Abstract][Full Text] [Related]
16. 99Tcm-DTPMP as a skeletal scintigraphy agent: distribution in rats in comparison with 99Tcm-MDP.
Láznícek M; Láznícková A; Budský F
Nucl Med Commun; 1996 Dec; 17(12):1016-20. PubMed ID: 9004296
[TBL] [Abstract][Full Text] [Related]
17. Age- and sex-related bone uptake of Tc-99m-HDP measured by whole-body bone scanning.
Brenner W; Sieweke N; Bohuslavizki KH; Kampen WU; Zuhayra M; Clausen M; Henze E
Nuklearmedizin; 2000 Aug; 39(5):127-32. PubMed ID: 10984888
[TBL] [Abstract][Full Text] [Related]
18. Does cisplatin chemotherapy decrease the MDP uptake of normal bone? An experimental study.
Ozdogan O; Ertay T; Arslan G; Sisman AR; Capa Kaya G; Yilmaz O; Coker C; Gure A; Durak H
Ann Nucl Med; 2008 Jun; 22(5):357-62. PubMed ID: 18600412
[TBL] [Abstract][Full Text] [Related]
19. Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment.
Moore AE; Blake GM; Taylor KA; Rana AE; Wong M; Chen P; Fogelman I
J Bone Miner Res; 2010 May; 25(5):960-7. PubMed ID: 19929434
[TBL] [Abstract][Full Text] [Related]
20. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
